Antibiotics for pneumonia therapy (Q40698572)

22 September 2017

1 reference

title

Antibiotics for pneumonia therapy (English)

1 reference

22 September 2017

0 references

Mandell LA

1

1 reference

22 September 2017

1 September 1994

1 reference

Medical Clinics of North America

22 September 2017

1 reference

22 September 2017

78

1 reference

22 September 2017

5

1 reference

22 September 2017

997-1014

1 reference

Pulmonary disposition of antimicrobial agents: methodological considerations

22 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930116-X

Anaerobic bacterial infections of the lung

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930116-X

General principles of antibiotic tissue penetration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930116-X

Endobronchial pH. Relevance of aminoglycoside activity in gram-negative bacillary pneumonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930116-X

Metronidazole in anaerobic infections: a review of its activity, pharmacokinetics and therapeutic use.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930116-X

beta-Lactam nomenclature.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930116-X

Double-blind study of endotracheal tobramycin in the treatment of gram-negative bacterial pneumonia. The Endotracheal Tobramycin Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930116-X

Postantibiotic suppression of bacterial growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930116-X

Ciprofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930116-X

Susceptibility of Anaerobic Bacteria to Metronidazole: Relative Resistance of Non-Spore-Forming Gram-Positive Baccilli

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930116-X

Post-antibiotic effects in experimental infection models: relationship to in-vitro phenomena and to treatment of infections in man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930116-X

The lethal action of aminoglycosides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930116-X

Role of pharmacokinetics in the outcome of infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930116-X

7 January 2021

Legionnaires' Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930116-X

Pulmonary epithelial sieving of small solutes in rat lungs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930116-X

Nosocomial pneumonia in patients receiving continuous mechanical ventilation. Prospective analysis of 52 episodes with use of a protected specimen brush and quantitative culture techniques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930116-X

Bioassay for A-56268 (TE-031) and identification of its major metabolite, 14-hydroxy-6-O-methyl erythromycin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930116-X

Role of serum protein binding and multiple antibiotic doses in the extravascular distribution of ceftizoxime and cefotaxime

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930116-X

Membrane transport of clindamycin in alveolar macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930116-X

Comparative in vitro activities of new 14-, 15-, and 16-membered macrolides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930116-X

Enhancement of the in vitro and in vivo activities of clarithromycin against Haemophilus influenzae by 14-hydroxy-clarithromycin, its major metabolite in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930116-X

The site concentrations of antimicrobial agents in the lung

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930116-X

Review of the in-vitro spectrum and characteristics of cefmetazole (CS-1170).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930116-X

Review of the in vitro spectrum of activity of imipenem

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930116-X

Osmiophilia of the saturated phospholipid, dipalmitoyl lecithin, and its relationship to the alveolar lining layer of the mammalian lung

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930116-X

Endotracheally Administered Antibiotics for Gram-Negative Bronchopneumonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930116-X

The interaction of reduced metronidazole with DNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930116-X

Gentamicin in the treatment of pulmonary infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930116-X

Initial antimicrobial treatment of hospital acquired pneumonia in adults: A conference report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930116-X

Antimicrobial treatment of community acquired pneumonia in adults: A conference report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930116-X

Association of aminoglycoside plasma levels with therapeutic outcome in gram-negative pneumonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930116-X

Chemical modification of erythromycins. I. Synthesis and antibacterial activity of 6-O-methylerythromycins A

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930116-X

Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy. American Thoracic Society. Medical Section of the American Lung Association

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930116-X

Activity of metronidazole and its hydroxy and acid metabolites against clinical isolates of anaerobic bacteria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930116-X

Risk factors and response to antibiotic therapy in adults with bacteremic pneumonia caused by penicillin-resistant pneumococci

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930116-X

Fluorometric measurement of ofloxacin uptake by human polymorphonuclear leukocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930116-X

Penetration of antibiotics into respiratory secretions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930116-X

Azithromycin. A review of its antimicrobial activity, pharmacokinetic properties and clinical efficacy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930116-X

In-vitro Comparison of Erythromycin, Lincomycin, and Clindamycin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930116-X

Antibiotic entry into human polymorphonuclear leukocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930116-X

Morphologic alterations of the blood-brain barrier with experimental meningitis in the rat. Temporal sequence and role of encapsulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930116-X

Nosocomial Respiratory Tract Infections in Multiple Trauma Patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930116-X

Diminished effect of gentamicin under anaerobic or hypercapnic conditions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930116-X

Symposium on antimicrobial agents. Metronidazole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930116-X

In vitro studies with Sch 21420 and Sch 22591: activity in comparison with six other aminoglycosides and synergy with penicillin against enterococci

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930116-X

Comparison of azithromycin and erythromycin in the treatment of atypical pneumonias

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930116-X

Aminoglycoside antibiotics in infectious diseases. An overview

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930116-X

Aztreonam: the first monobactam

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930116-X

Review of in vitro activity of third-generation cephalosporins and other newer beta-lactam antibiotics against clinically important bacteria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930116-X

Cefotetan. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930116-X

Mode of action and in-vitro activity of vancomycin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930116-X

The clinical relevance of protein binding and tissue concentrations in antimicrobial therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930116-X

Haemophilus influenzae lipopolysaccharide-induced blood brain barrier permeability during experimental meningitis in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930116-X

Tetracyclines, chloramphenicol, erythromycin, and clindamycin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930116-X

Trimethoprim-Sulfamethoxazole: In Vitro Microbiological Aspects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930116-X

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0025-7125(16)30116-X

1 reference

22 September 2017

1 reference

PubMed ID

8078379